Sarcoidosis, malignancy and immune checkpoint blockade

Immunotherapy. 2017 Oct;9(13):1051-1053. doi: 10.2217/imt-2017-0128.
No abstract available

Keywords: immune checkpoint inhibitor; immune related adverse event; sarcoid-like reaction; sarcoidosis.

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents, Immunological / adverse effects
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Diagnosis, Differential
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Ipilimumab / adverse effects
  • Neoplasms / complications
  • Neoplasms / drug therapy*
  • Sarcoidosis / diagnosis*
  • Sarcoidosis / drug therapy
  • Sarcoidosis / etiology
  • Sarcoidosis / pathology
  • Steroids / therapeutic use

Substances

  • Antineoplastic Agents, Immunological
  • Immunosuppressive Agents
  • Ipilimumab
  • Steroids